Prednisone – 20 mg 1x a day (usual dose of 5 mg Daily) Used for Immunosuppression for Kidney
Myfortic: 720 mg BID
Prophylaxis of organ rejection concomitantly with cyclosporine and corticosteroids in patients receiving allogeneic renal transplant Cautions: Mouth ulceration, gum hyperplasia, gingivitis, dry mouth, dysphagia, oral moniliasis, and stomatitis. Reductions in platelet counts Acyclovir-Valacyclovir: Mycophenolate may increase the serum concentration of Acyclovir-Valacyclovir. Acyclovir-Valacyclovir may increase the serum concentration of Mycophenolate. Risk C: CycloSPORINE (Systemic): May decrease the serum concentration of Mycophenolate. Specifically, cyclosporine may decrease concentrations of the active metabolite mycophenolic acid. Risk D: Consider therapy modification
Cyclosporine: 150 mg po q. am and 125 mg p.o. q.pm
Prophylaxis of organ rejection in kidney transplants, has been used with azathioprine and/or corticosteroids Cautions: Mouth sores, swallowing difficulty, gingivitis, gum hyperplasia, xerostomia (normal salivary flow resumes upon discontinuation), abnormal taste, tongue disorder, tooth disorder, and gingival bleeding. Action: Inhibition of production and release of interleukin II and inhibits interleukin II-induced activation of resting T-lymphocytes. May cause significant hyperkalemia and hyperuricemia. May cause seizures, particularly if used with high-dose corticosteroids. Encephalopathy has been reported, predisposing factors include hypertension, hypomagnesemia, hypocholesterolemia, high-dose corticosteroids, high cyclosporine serum concentration, and graftversus-host disease; may be more common in patients with liver transplant. Antifungal Agents (Azole Derivatives, Systemic): May decrease the metabolism of CycloSPORINE (Systemic). Risk D: Consider therapy modification
Aspirin 325 mg p. Hemorrhage may occur at virtually any site.5 mg/dL and serum phosphorus <4. adjunctive therapy in revascularization procedures (coronary artery bypass graft [CABG]. Treatment should only be started with serum 25(OH) D >30 ng/mL.o. IDDM) to improve glycemic control Humulin – sliding scale Tx of Type 1 diabetes mellitus
. stent implantation Key adverse event(s) related to dental treatment: As with all drugs which may affect hemostasis. risk is dependent on multiple variables including dosage. injection: Management of hypocalcemia in patients on chronic renal dialysis. concurrent use of multiple agents which alter hemostasis. osteoarthritis. bleeding is associated with aspirin. and fever.25 mcg (MICROGRAMS) p. inflammation. acute ischemic stroke. and patient susceptibility. serum calcium <9. CKD stage 4: Oral: 0.Limit Grapefruit Juice: May decrease the metabolism of CycloSPORINE (Systemic). Risk D: Consider therapy modification
Calcitriol 0. prevention and treatment of myocardial infarction (MI). rheumatic fever. serum iPTH >110 pg/mL. management of secondary hyperparathyroidism in patients with chronic kidney disease (CKD) Effects on Dental Tx: Metallic taste and xerostomia (normal salivary flow resumes upon discontinuation). percutaneous transluminal coronary angioplasty [PTCA]. and transient ischemic episodes. Monday and Thursday
Oral. management of rheumatoid arthritis.o. 7-10 day
Lantus: 18 units subcutaneously daily (Long acting insulin analog) – MORNING APPOINTMENTS Treatment of type 1 diabetes mellitus (insulin dependent.25 mcg/day. twice weekly. carotid endarterectomy). daily
Treatment of mild-to-moderate pain.
orthostatic hypotension. ventricular arrhythmia and even death. insulin detemir. Patients with type 1 diabetes (insulin dependent) should be appointed for dental treatment in the morning in order to minimize chance of stressinduced hypoglycemia.
IRON: 325 mg p.WARNING: Hypokalemia: Insulin (especially I. temporary or permanent brain damage. Herb/Nutraceutical: Avoid dong quai if using for hypertension (has estrogenic activity). and abnormal taste. kava kava. If left untreated. or other stressors. use of long-acting insulin preparations (eg. treatment of iron deficiency anemia Vitamin D 50. emotional disturbances. daily (STARTED DURING HOSPITALIZION DUE TO STRESS DOSE STEROIDS)
. Hypoglycemia may result from increased work or exercise without eating. Avoid ephedra. unconsciousness. Hypoglycemia: The most common adverse effect of insulin is hypoglycemia. Monitor serum potassium and supplement potassium when necessary. Avoid valerian. gotu kola (may increase CNS depression). ginseng (may worsen hypertension). Ethanol: Avoid ethanol (may increase CNS depression). The timing of hypoglycemia differs among various insulin formulations. daily –prevention. loop diuretic use). or even death.V. St John's wort. Insulin requirements may be altered during illness.o.
Catapres – 0. Use with caution in patients at risk for hypokalemia (eg.o. yohimbe. possibly producing hypokalemia.2 mg transdermal patch once weekly (CLONIDINE) Transdermal patch: Management of hypertension (monotherapy or as adjunctive therapy) Significant xerostomia (normal salivary flow resumes upon discontinuation). insulin glargine) may delay recovery from hypoglycemia.000 units po daily
Omeprazole – 20 mg p. hypokalemia may result in respiratory paralysis. Profound and prolonged episodes of hypoglycemia may result in convulsions. insulin) causes a shift of potassium from the extracellular space to the intracellular space.
dry mouth. Amphetamines: Proton Pump Inhibitors may increase the serum concentration of Amphetamines.To delay the progression of nephropathy and reduce risks of cardiovascular events in hypertensive patients with type 1 or 2 diabetes mellitus. diabetic nephropathy. treatment of heartburn and other symptoms associated with gastroesophageal reflux disease (GERD). and mucosal atrophy (tongue). Specifically.Short-term (4-8 weeks) treatment of active duodenal ulcer disease or active benign gastric ulcer. long-term treatment of pathological hypersecretory conditions. Risk C: Monitor therapy Thiazide Diuretics: Analgesics (Opioid) may enhance the orthostatic hypotensive effect of Thiazide Diuretics. Risk C: Monitor therapy
Oxycodone (5 mg po daily) – pain Management of moderate-to-severe pain. hypertensive crisis. esophageal candidiasis. maintenance healing of erosive esophagitis. use with caution in patients with hypovolemia. cardiovascular disease (including acute MI). Total exposure to Amphetamines is not significantly changed. hypertension
. pylori eradication to reduce the risk of duodenal ulcer recurrence Effect on Dental Tx: Taste perversion. short-term (4-8 weeks) treatment of endoscopically-diagnosed erosive esophagitis. Risk C: Monitor therapy Instruct patient to avoid high-fat meals when taking some products
ALLERGY: VASOTEC . Hypotension: May cause hypotension. data indicate that Proton Pump Inhibitors may increase the rate at which Amphetamines are absorbed. or drugs which may exaggerate hypotensive effects (including phenothiazines or general anesthetics). Amphetamines: May enhance the analgesic effect of Analgesics (Opioid). as part of a multidrug regimen for H. normally used in combination with nonopioid analgesics OxyContin® is indicated for around-the-clock management of moderate-tosevere pain when an analgesic is needed for an extended period of time.
secondary to scleroderma renal crisis. postmyocardial infarction for prevention of ventricular failure
. Bartter's syndrome. idiopathic edema. diagnosis of aldosteronism.